| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.03. | Almirall to license Eloxx's ZKN-013 for rare skin conditions | 3 | Pharmaceutical Technology | ||
| 13.03. | Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to license ZKN-013 for rare dermatological diseases | 258 | GlobeNewswire (Europe) | Almirall obtains exclusive global rights to develop and commercialize ZKN-013 for the treatment of rare dermatological and other diseases associated with nonsense mutationsZKN-013 is a phase I ready... ► Artikel lesen | |
| 13.03. | Almirall, S.A.: Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to License ZKN-013 for Rare Dermatological Diseases | 312 | Business Wire | Almirall obtains exclusive global rights to develop and commercialize ZKN-013 for the treatment of rare dermatological and other diseases associated with nonsense mutations ZKN-013 is a... ► Artikel lesen | |
| 13.03. | Almirall signs yes-nonsense skin disease deal with Eloxx for $3M upfront | 3 | FierceBiotech | ||
| 13.03. | Almirall and Eloxx Pharmaceuticals Enter Exclusive License agreement for ZKN-013 | 2 | Contract Pharma | ||
| 13.03. | Almirall gains rights to Eloxx's rare dermatological disease asset in deal worth over $470m | 3 | PMLiVE | ||
| 13.03. | ALMIRALL, S.A.: License agreement with Eloxx Pharmaceuticals | 5 | CNMV | ||
| 26.02. | Almirall: investors to focus on Lebrikizumab Pipeline, sales of which could peak at €450m | 9 | thecorner.eu | ||
| 21.02. | Almirall gains rights to Novo Nordisk's IL-21 blocker for dermatological diseases | 16 | PMLiVE | ||
| 20.02. | Almirall, S.A. reports FY results | 3 | Seeking Alpha | ||
| 19.02. | Almirall licenses IL-21 antibody from Novo Nordisk | 16 | Pharmaceutical Technology | ||
| 19.02. | Almirall S.A.: Almirall Licenses an Anti-IL-21 Monoclonal Antibody From Novo Nordisk to Develop It as a First-in-Class Agent in Dermatology | 768 | Business Wire | Almirall obtains exclusive global rights to develop and commercialize NN-8828 for use in several fields, including immune inflammatory dermatological diseases NN-8828 is an IL-21 blocker... ► Artikel lesen | |
| 19.02. | ALMIRALL, S.A.: License agreement with Novo Nordisk | 16 | CNMV | ||
| 19.02. | ALMIRALL, S.A.: Presentation FY2023 Financial Results | 12 | CNMV | ||
| 19.02. | ALMIRALL, S.A.: Webcast with analysts and institutional investors: Presentation of FY 2023 Financial Results | 2 | CNMV | ||
| 19.02. | Almirall, S.A.: Almirall continues its progress to leadership in Medical Dermatology driven by strong growth in the European Dermatology business | 441 | Business Wire | Almirall's Full-Year 2023 Results
Company revenue growth driven by the strong performance of the European Dermatology business (+17% year-on-year) based on key growth divers and new launches:... ► Artikel lesen | |
| 19.02. | Almirall continues its progress to leadership in Medical Dermatology driven by strong growth in the European Dermatology business | 171 | Business Wire | BARCELONA--(BUSINESS WIRE)--Almirall, S.A. (ALM) a global biopharmaceutical company based in Barcelona, today announced its full-year 2023 financial results.
Financial highlights (€ rounded... ► Artikel lesen | |
| 09.02. | Almirall and CRG partner to advance therapeutic approaches for atopic dermatitis | 1 | PMLiVE | ||
| 01.02. | Almirall and Microsoft partner to accelerate digital transformation in medical dermatology | 4 | PMLiVE | ||
| 01.02. | Almirall and Microsoft partner for dermatological drug development | 5 | Pharmaceutical Technology |
Seite:
1 2 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 3.170 |
| MERCEDES-BENZ | 2.600 |
| NEL | 2.567 |
| SIEMENS ENERGY | 2.366 |
| PLUG POWER | 2.223 |
| BAYER | 2.047 |
| TUI | 1.987 |
| ALLIANZ | 1.809 |
| PALANTIR TECHNOLOGIES | 1.807 |
| BYD | 1.502 |
| NVIDIA | 1.492 |
| DEUTSCHE BANK | 1.395 |
| DEUTSCHE LUFTHANSA | 1.295 |
| INFINEON | 1.106 |
| RWE | 1.105 |
| VARTA | 1.066 |
| PUMA | 1.062 |
| VOLKSWAGEN | 1.026 |
| SUPER MICRO COMPUTER | 1.006 |
| RENK GROUP | 1.003 |
| RHEINMETALL | 993 |
| TESLA | 989 |
| AIXTRON SE | 932 |
| BORUSSIA DORTMUND | 908 |
| SMA SOLAR | 905 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
